Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 147.54M P/E 50.50 EPS this Y - Ern Qtrly Grth -
Income -1.7M Forward P/E 25.25 EPS next Y - 50D Avg Chg -9.00%
Sales 72.57M PEG - EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 2.54 EPS next 5Y - 52W High Chg -23.00%
Recommedations 2.00 Quick Ratio 0.95 Shares Outstanding 153.90M 52W Low Chg 1.00%
Insider Own 27.93% ROA 0.31% Shares Float 129.14M Beta 0.42
Inst Own 20.40% ROE -2.79% Shares Shorted/Prior -/- Price 1.01
Gross Margin 50.68% Profit Margin -2.34% Avg. Volume 2,024 Target Price -
Oper. Margin 3.20% Earnings Date Nov 11 Volume 14,650 Change -4.17%
About HAMILTON THORNE LTD

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.

HAMILTON THORNE LTD News
05:04 PM 3 Promising TSX Penny Stocks With Market Caps Under CA$400M
11/14/24 Hamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2024
10/21/24 3 TSX Penny Stocks With Market Caps Under CA$400M
10/17/24 Individual investors account for 52% of Hamilton Thorne Ltd.'s (TSE:HTL) ownership, while institutions account for 32%
10/17/24 Hamilton Thorne Provides Update on Going Private Transaction
09/17/24 Hamilton Thorne Announces Shareholder Approval of Going Private Transaction
08/26/24 Hamilton Thorne Announces Mailing of Meeting Materials and Receipt of Interim Order in Respect of Going Private Transaction
08/14/24 Hamilton Thorne Reports Revenue for the Quarter and Six Months Ended June 30, 2024, and Confirms Annual Guidance
08/07/24 Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024
07/29/24 Hamilton Thorne Ltd. (TSE:HTL) Shares Could Be 49% Below Their Intrinsic Value Estimate
06:30 AM Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2.25 Per Share in Cash
06/30/24 Here's What's Concerning About Hamilton Thorne's (TSE:HTL) Returns On Capital
06/11/24 Hamilton Thorne Announces Voting Results of 2024 Annual Meeting
05/23/24 Hamilton Thorne (TSE:HTL) shareholders have earned a 5.6% CAGR over the last five years
05/14/24 Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter Ended March 31, 2024, and Confirms Annual Guidance
05/06/24 Hamilton Thorne to Announce Q1 2024 Financial Results and Hold Conference Call on May 14, 2024
04/26/24 Hamilton Thorne Ltd.'s (TSE:HTL) largest shareholders are retail investors with 51% ownership, institutions own 33%
04/10/24 Hamilton Thorne Ltd. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
03/27/24 Hamilton Thorne Reports Record Revenue and EBITDA for the Quarter and Year Ended December 31, 2023
03/21/24 Hamilton Thorne to Announce Q4 and Full Year 2023 Financial Results and Hold Conference Call on March 27, 2024